Unterrainer, L.M.; Beyer, L.; Zacherl, M.J.; Gildehaus, F.J.; Todica, A.; Kunte, S.C.; Holzgreve, A.; Sheikh, G.T.; Herlemann, A.; Casuscelli, J.;
et al. Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T. Biomedicines 2022, 10, 946.
https://doi.org/10.3390/biomedicines10050946
AMA Style
Unterrainer LM, Beyer L, Zacherl MJ, Gildehaus FJ, Todica A, Kunte SC, Holzgreve A, Sheikh GT, Herlemann A, Casuscelli J,
et al. Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T. Biomedicines. 2022; 10(5):946.
https://doi.org/10.3390/biomedicines10050946
Chicago/Turabian Style
Unterrainer, Lena M., Leonie Beyer, Mathias J. Zacherl, Franz J. Gildehaus, Andrei Todica, Sophie C. Kunte, Adrien Holzgreve, Gabriel T. Sheikh, Annika Herlemann, Jozefina Casuscelli,
and et al. 2022. "Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T" Biomedicines 10, no. 5: 946.
https://doi.org/10.3390/biomedicines10050946
APA Style
Unterrainer, L. M., Beyer, L., Zacherl, M. J., Gildehaus, F. J., Todica, A., Kunte, S. C., Holzgreve, A., Sheikh, G. T., Herlemann, A., Casuscelli, J., Brendel, M., Albert, N. L., Wenter, V., Schmidt-Hegemann, N.-S., Kunz, W. G., Cyran, C. C., Ricke, J., Stief, C. G., Bartenstein, P.,
... Unterrainer, M.
(2022). Total Tumor Volume on 18F-PSMA-1007 PET as Additional Imaging Biomarker in mCRPC Patients Undergoing PSMA-Targeted Alpha Therapy with 225Ac-PSMA-I&T. Biomedicines, 10(5), 946.
https://doi.org/10.3390/biomedicines10050946
